CANCELLED - SECTION 8
section 8
on 25 Oct 2024
Last Applicant/ Owned by
829 INCORRIGIBLE CIRCLE
LONGMONT
CO
80504
Serial Number
87039914 filed on 17th May 2016
Registration Number
5443965 registered on 10th Apr 2018
Correspondent Address
Kurt Leyendecker
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
RES-Q-RINSE
Pharmaceutical preparations for treatment of nasal cavity conditions, namely, intra-nasal polyps, acute/chronic sinusitis, nasal congestion, rhinitis--vasomotor/allergic, rhinorrhea, inferior turbinate hypertrophy, nasal mucositis and hereditary hemorrhagic telangectasia
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for treatment of nasal cavity conditions, namely, intra-nasal polyps, acute/chronic sinusitis, nasal congestion, rhinitis--vasomotor/allergic, rhinorrhea, inferior turbinate hypertrophy, nasal mucositis and hereditary hemorrhagic telangectasia
First Use Date in General
05th Feb 2018
First Use Date in Commerce
05th Feb 2018
Mark Details
Serial Number
No 87039914
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Oct 2024 | CANCELLED SEC. 8 (6-YR) |
| 10th Apr 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 10th Apr 2018 | REGISTERED-PRINCIPAL REGISTER |
| 09th Mar 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 08th Mar 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 28th Feb 2018 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 22nd Feb 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| 20th Feb 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Feb 2018 | USE AMENDMENT FILED |
| 06th Feb 2018 | TEAS STATEMENT OF USE RECEIVED |